Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 7Lymphoma, Large B-Cell, Diffuse 4Lymphoma 4Carcinoma, Non-Small-Cell Lung 4Burkitt Lymphoma 4Ovarian Neoplasms 3Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell 2Lung Neoplasms 2Head and Neck Neoplasms 2Xerostomia 1Thyroid Carcinoma, Anaplastic 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Recurrence 1Prostatic Neoplasms 1Previously Treated Non Small Cell Lung Cancer 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pain 1Osteosarcoma 1Neutropenia 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Multiple Myeloma 1

Interventions

Cyclophosphamide 3Zoledronic Acid 2Vincristine 2Tranexamic Acid 2Temozolomide 2Magnetic Resonance Spectroscopy 2Irinotecan 2Ibandronic Acid 2Etoposide 2Doxorubicin 2samarium Sm-153 lexidronam 1robatumumab 1pegfilgrastim 1eltrombopag 1delta 24-sterol reductase 1Sodium Pertechnetate Tc 99m 1Sodium Chloride 1Samarium 1Radiation 1Pregabalin 1Plicamycin 1Neutrons 1Ifosfamide 1Histocompatibility Testing 1Guanabenz 1Gemcitabine 1Fluoridation 1Fibrin Tissue Adhesive 1Etanercept 1Diathermy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Bone Neoplasms × pegfilgrastim × Clear all
NCT01313884 2017-11-24

Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma

Stanford University

Phase 2 Terminated
3 enrolled 7 charts
Sarcoma

Bone Neoplasms, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡